GO:0034148 negative regulation of toll-like receptor 5 signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034148 describes any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 5 (TLR5) signaling.
• TLR5 recognizes bacterial flagellin and activates NF-kB and MAPK pathways; negative regulation prevents excessive inflammation.
• Key negative regulators include A20 (TNFAIP3), which is rapidly induced in intestinal epithelial cells to dampen TLR5 signaling.
• Flagellin-induced tolerance in polarized intestinal epithelial cells is a classic example of negative regulation of TLR5 signaling.
• Dysregulation of TLR5 signaling is linked to hepatic injury, inflammatory bowel disease, and cancer.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect the causal role of negative regulators in this pathway.
Description
Toll-like receptor 5 (TLR5) is a pattern recognition receptor that detects bacterial flagellin and initiates innate immune signaling. While TLR5 activation is crucial for host defense, uncontrolled signaling can lead to chronic inflammation and tissue damage. Therefore, negative regulation of TLR5 signaling (GO:0034148) is essential to maintain immune homeostasis. This biological process encompasses molecular mechanisms that attenuate or terminate TLR5-mediated responses, including the induction of negative regulators such as A20 and the establishment of tolerance in epithelial cells. Understanding GO:0034148 is critical for researchers studying inflammatory diseases, host-pathogen interactions, and the development of therapeutics that modulate TLR5 activity.
negative regulation of toll-like receptor 5 signaling pathway At A Glance
| GO ID | GO:0034148 |
|---|---|
| GO term | negative regulation of toll-like receptor 5 signaling pathway |
| Ontology | biological_process |
| Synonym | negative regulation of TLR5 signaling pathway |
| Major function | Attenuation of TLR5-mediated immune signaling to prevent excessive inflammation |
| Related pathway | Toll-like receptor signaling, NF-kB and MAPK cascades |
| Key negative regulators | A20 (TNFAIP3), TLR5S (soluble TLR5), and others |
| Physiological context | Intestinal epithelial tolerance, hepatic protection, and immune homeostasis |
What Is GO:0034148?
GO:0034148 (negative regulation of toll-like receptor 5 signaling pathway) is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 5 signaling pathway. This includes mechanisms that desensitize the receptor, degrade signaling intermediates, or induce negative feedback loops, ultimately limiting the inflammatory response triggered by flagellin.
Why Is negative regulation of toll-like receptor 5 signaling pathway Important in Cell Biology?
Negative regulation of TLR5 signaling is vital for preventing chronic inflammatory diseases and maintaining immune tolerance to commensal bacteria. Dysregulation of this process can lead to exacerbated tissue injury, as seen in concanavalin A-induced hepatic injury and inflammatory bowel diseases. Moreover, understanding how TLR5 signaling is turned off provides therapeutic opportunities for modulating innate immunity in infections and autoimmune conditions.
• Prevents excessive inflammation in response to bacterial flagellin.
• Maintains intestinal epithelial homeostasis and tolerance.
• Protects against T-cell/NKT-cell mediated hepatic injury.
• Involved in host-pathogen interactions and bacterial clearance.
• Dysregulation linked to inflammatory bowel disease and colitis.
• Potential target for anti-inflammatory drug development.
• Key for understanding vaccine adjuvanticity and flagellin-based therapies.
• Relevant to cancer immunotherapy due to TLR5 expression in tumors.
• Model organism studies (e.g., fish) reveal conserved regulatory mechanisms.
• CRISPR screening can identify novel negative regulators of TLR5 signaling.
What Happens During negative regulation of toll-like receptor 5 signaling pathway?
Induction of negative feedback regulators
In simple terms: The cell quickly makes proteins that shut down the TLR5 signal after it has been activated.
Upon TLR5 activation by flagellin, signaling cascades lead to NF-kB and MAPK activation, which in turn induce the expression of negative regulators such as A20 (TNFAIP3). A20 is an early responding negative regulator of TLR5 signaling in intestinal epithelial cells, acting to deubiquitinate signaling intermediates and terminate the response. This feedback loop is critical for preventing sustained inflammation.
Receptor desensitization and tolerance
In simple terms: Repeated exposure to flagellin makes the cell less responsive, a phenomenon called tolerance.
Prolonged or repeated stimulation of TLR5 with flagellin induces a state of tolerance in polarized intestinal epithelial cells, characterized by reduced NF-kB activation and decreased expression of pro-inflammatory cytokines. This tolerance is a form of negative regulation that involves downregulation of surface TLR5 and upregulation of inhibitory molecules.
Soluble decoy receptors
In simple terms: Some organisms produce a soluble form of TLR5 that soaks up flagellin and prevents it from activating the membrane receptor.
In teleost fish such as Epinephelus coioides, a soluble form of TLR5 (TLR5S) negatively regulates the membrane-bound TLR5 (TLR5M)-mediated NF-kB signaling pathway by acting as a decoy receptor for flagellin. This mechanism highlights an evolutionary conserved strategy to modulate TLR5 signaling.
Inhibition of downstream kinases
In simple terms: Specific enzymes can block the kinases that transmit the signal from TLR5.
The p38 MAPK pathway is coupled to TLR5 and mediates gene regulation in response to Pseudomonas aeruginosa infection in human airway epithelial cells. Negative regulation can occur through phosphatases or inhibitory proteins that dephosphorylate or sequester p38 and other MAPKs, thereby dampening the TLR5 response.
Cross-regulation by other TLRs
In simple terms: Activation of other immune receptors can interfere with TLR5 signaling to balance the overall response.
TLR signaling pathways are interconnected, and activation of other TLRs or cytokine receptors can induce negative regulators that also affect TLR5. For example, anti-inflammatory cytokines such as IL-10 can suppress TLR5-mediated NF-kB activation, contributing to the negative regulation of this pathway.
Key Genes Involved in GO:0034148 negative regulation of toll-like receptor 5 signaling pathway
The following genes and proteins are key players in the negative regulation of TLR5 signaling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNFAIP3 (A20) | Deubiquitinase that terminates TLR5 signaling | Early negative regulator in intestinal epithelial cells |
| TLR5 | Receptor for flagellin; target of negative regulation | Central to the pathway; knockout models available |
| TLR5S | Soluble decoy receptor for flagellin | Negatively regulates TLR5M in fish |
| MYD88 | Adaptor protein for TLR5 signaling | Knockout abolishes TLR5 signaling; used to study negative regulators |
| NFKB1 | Transcription factor activated by TLR5 | Readout of pathway activity; negative regulators reduce its activation |
| MAPK14 (p38) | Kinase coupled to TLR5 | Mediates gene regulation; target of negative regulation |
| IL10 | Anti-inflammatory cytokine | Suppresses TLR5 signaling in immune cells |
| SOCS1 | Suppressor of cytokine signaling | Potential negative regulator of TLR5-induced inflammation |
| IRAK3 | Inhibitory kinase | Negatively regulates TLR signaling including TLR5 |
| TOLLIP | Inhibitory adaptor | Suppresses TLR5-mediated NF-kB activation |
| TRAF3 | Negative regulator of TLR signaling | Limits TLR5-induced pro-inflammatory responses |
| UBQLN1 | Ubiquitin-like protein | May regulate TLR5 stability |
| PELI1 | E3 ubiquitin ligase | Modulates TLR5 signaling |
| DUSP1 | Phosphatase | Inactivates MAPKs downstream of TLR5 |
| TNIP1 | A20-binding inhibitor of NF-kB | Cooperates with A20 to inhibit TLR5 signaling |
| ZFAND5 | Zinc finger protein | Potential negative regulator identified in screens |
| RNF216 | E3 ubiquitin ligase | Negatively regulates TLR5 signaling |
| OTULIN | Deubiquitinase | Regulates NF-kB activation downstream of TLR5 |
How Is negative regulation of toll-like receptor 5 signaling pathway Regulated?
The negative regulation of TLR5 signaling is itself tightly controlled. A20 (TNFAIP3) is rapidly induced upon TLR5 activation and acts as a central negative feedback regulator. Its expression is dependent on NF-kB, creating a negative feedback loop. Additionally, soluble decoy receptors like TLR5S are regulated at the transcriptional level in response to bacterial infection. Cross-talk with other signaling pathways, such as the p38 MAPK pathway, can modulate the strength of negative regulation. In intestinal epithelial cells, repeated flagellin exposure leads to tolerance, which involves epigenetic and transcriptional changes that sustain negative regulation.
negative regulation of toll-like receptor 5 signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNFAIP3 (A20) | Inflammatory bowel disease, colitis | Intestinal epithelial cell-specific knockout mice |
| TLR5 | Hepatic injury, metabolic syndrome | TLR5 knockout mice |
| MYD88 | Immunodeficiency, chronic inflammation | MyD88 knockout macrophages |
| MAPK14 (p38) | Airway inflammation | p38 inhibitor-treated airway epithelial cells |
| IL10 | IBD, autoimmunity | IL-10 knockout mice |
Inflammatory Bowel Disease (IBD)
Impaired negative regulation of TLR5 signaling in intestinal epithelial cells can lead to chronic inflammation and contribute to IBD pathogenesis. A20 deficiency in intestinal epithelial cells results in exacerbated TLR5-mediated inflammation and colitis in mice.
Liver Injury
TLR5 signaling restrains T-cell/NKT-cell activation and protects against concanavalin A-induced hepatic injury. Negative regulation of TLR5 signaling is crucial for limiting liver damage; dysregulation may worsen hepatitis.
Cancer
TLR5 expression in tumor cells can promote or inhibit tumor progression depending on context. Negative regulators of TLR5 signaling may influence cancer immunotherapy outcomes by modulating the inflammatory tumor microenvironment.
Bacterial Infections
Pathogens such as Pseudomonas aeruginosa activate TLR5, and negative regulation prevents excessive tissue damage during infection. Defects in negative regulation can lead to severe inflammatory responses.
From negative regulation of toll-like receptor 5 signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does A20 negatively regulate TLR5 signaling in intestinal epithelium? | A20 conditional knockout in intestinal epithelial cells |
| What is the role of TLR5S in TLR5M signaling? | TLR5S overexpression in fish cell lines |
| How does flagellin tolerance affect TLR5 signaling? | Polarized intestinal epithelial cell monolayers |
| Which kinases are negatively regulated downstream of TLR5? | p38 MAPK knockout or knockdown cells |
| Can CRISPR screen identify novel negative regulators of TLR5? | Genome-wide CRISPR knockout library in TLR5-expressing cells |
| Does point mutation in TLR5 affect negative regulation? | Knock-in mice with TLR5 mutations |
How to Study the negative regulation of toll-like receptor 5 signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Loss-of-function effects on TLR5 signaling | Identify novel negative regulators |
| RNA-seq | Transcriptional changes | Measure feedback gene induction |
| Proteomics | Protein abundance and modifications | Detect ubiquitination of signaling proteins |
| NF-kB reporter assay | NF-kB activation | Quantify negative regulation |
| Western blot | Phosphorylation of p38, IkB | Assess pathway inhibition |
| ELISA | Cytokine secretion (e.g., IL-8, TNF) | Measure inflammatory output |
| Co-immunoprecipitation | Protein-protein interactions | Identify A20 binding partners |
| Flow cytometry | Surface TLR5 expression | Assess receptor downregulation |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes whose loss enhances TLR5 signaling, revealing novel negative regulators. This approach has been used to discover A20 and other inhibitors.
RNA Sequencing (RNA-seq)
RNA-seq of cells stimulated with flagellin in the presence or absence of negative regulators can reveal transcriptional programs and feedback loops.
Proteomics and Ubiquitinomics
Mass spectrometry-based proteomics can identify ubiquitination events on TLR5 signaling intermediates, which are reversed by deubiquitinases like A20.
Imaging and Reporter Assays
NF-kB luciferase reporter assays and immunofluorescence can visualize TLR5 signaling activity and its negative regulation in real time.
How CRISPR Can Be Used to Study GO:0034148 negative regulation of toll-like receptor 5 signaling pathway
Knockout
CRISPR knockout of negative regulators such as TNFAIP3 (A20) in cell lines or mice leads to hyperactivation of TLR5 signaling, confirming their inhibitory role. Knockout of TLR5 itself abolishes the pathway, providing a baseline for negative regulation studies.
Point Mutation
Point mutations in TLR5 or its negative regulators can disrupt specific interaction domains, allowing researchers to dissect molecular mechanisms. For example, mutation of the deubiquitinase catalytic site of A20 prevents its negative regulation of TLR5 signaling.
Knock-in
Knock-in of tagged versions of negative regulators (e.g., HA-A20) enables chromatin immunoprecipitation and proteomic studies to map their interactions and modifications during TLR5 signaling.
Overexpression
Overexpression of negative regulators such as TLR5S or A20 in cell lines can suppress TLR5-mediated NF-kB activation, providing gain-of-function evidence for their inhibitory roles.
How EDITGENE Supports negative regulation of toll-like receptor 5 signaling pathway Research
Researchers studying negative regulation of toll-like receptor 5 signaling pathway-related genes often need to determine whether a candidate gene is causally involved in dampening TLR5 responses. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of negative regulators in inflammatory and infectious disease contexts.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of toll-like receptor 5 signaling pathway research.
Frequently Asked Questions About negative regulation of toll-like receptor 5 signaling pathway
What is GO:0034148?
GO:0034148 is the Gene Ontology term for negative regulation of toll-like receptor 5 signaling pathway, describing any process that stops, prevents, or reduces TLR5 signaling.
What genes are involved in negative regulation of TLR5 signaling?
Key genes include TNFAIP3 (A20), TLR5S, SOCS1, TOLLIP, IRAK3, and others that dampen TLR5-mediated NF-kB and MAPK activation.
How does A20 negatively regulate TLR5 signaling?
A20 is rapidly induced upon TLR5 activation and deubiquitinates signaling intermediates, terminating the response in intestinal epithelial cells.
What is flagellin-induced tolerance?
It is a state of reduced responsiveness to flagellin after repeated exposure, representing a form of negative regulation of TLR5 signaling in epithelial cells.
Which diseases are linked to defective negative regulation of TLR5 signaling?
Inflammatory bowel disease, hepatic injury, and chronic infections are associated with impaired negative regulation of TLR5 signaling.
What model systems are used to study negative regulation of TLR5 signaling?
Common models include knockout mice, intestinal epithelial cell lines, and CRISPR screens in human cells.
How can CRISPR help study negative regulation of TLR5 signaling?
CRISPR knockout, knock-in, and overexpression allow functional validation of candidate negative regulators and identification of novel players.
What is the role of TLR5S in TLR5 signaling?
TLR5S is a soluble decoy receptor that binds flagellin and prevents TLR5M-mediated NF-kB activation in fish.
Is negative regulation of TLR5 signaling conserved across species?
Yes, studies in fish and mammals show conserved mechanisms, including soluble decoy receptors and A20 induction.
What methods are used to measure negative regulation of TLR5 signaling?
NF-kB reporter assays, cytokine ELISAs, Western blot for phospho-p38, and RNA-seq are commonly used.
Conclusion
Negative regulation of toll-like receptor 5 signaling (GO:0034148) is a critical biological process that prevents excessive inflammation and maintains immune homeostasis. Key regulators such as A20 and TLR5S provide attractive targets for therapeutic intervention in inflammatory diseases. Leveraging CRISPR-based models and screening technologies will continue to uncover novel mechanisms and translate them into clinical applications.
References
- 1. Muzio M et al.. 2000. Toll-like receptor family and signalling pathway.. Biochem Soc Trans 28(5):563-6 PMID: 11044375
- 2. Wang L et al.. 2017. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.. Hepatology 65(6):2059-2073 PMID: 28273362
- 3. Sun J et al.. 2007. Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells.. Am J Physiol Gastrointest Liver Physiol 292(3):G767-78 PMID: 17138965
- 4. Zhang Z et al.. 2007. The p38 mitogen-activated protein kinase signaling pathway is coupled to Toll-like receptor 5 to mediate gene regulation in response to Pseudomonas aeruginosa infection in human airway epithelial cells.. Infect Immun 75(12):5985-92 PMID: 17908812
- 5. Kaisho T et al.. 2001. Toll-like receptors and their signaling mechanism in innate immunity.. Acta Odontol Scand 59(3):124-30 PMID: 11501880
- 6. Basu M et al.. 2012. Inductive expression of toll-like receptor 5 (TLR5) and associated downstream signaling molecules following ligand exposure and bacterial infection in the Indian major carp, mrigal (Cirrhinus mrigala).. Fish Shellfish Immunol 32(1):121-31 PMID: 22085689
- 7. He L et al.. 2023. TLR5S negatively regulates the TLR5M-mediated NF-κB signaling pathway in Epinephelus coioides.. Int J Biol Macromol 249:126048 PMID: 37517756
- 8. Oshima N et al.. 2010. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation.. Clin Exp Immunol 159(2):185-98 PMID: 19912257
